Delivery Order SPE2DB22D3501-SPE2DB25FVU93
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,690.80 and a period of performance through May 6, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is for the delivery of OMNIPAQUE 300 MG/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a total ceiling value of $1,652.90. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 19, 2024. The contract does not have a set-aside designation. Amerisourcebergen...
This federal contract award is for the delivery of OMNIPAQUE 300 MG/ML INFU BTL 100ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,171.23 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 15, 2024. There is no set-aside designation mentioned in the information...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,866.06 firm-fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract has an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,014.48, is a delivery order under an Indefinite Delivery Contract (IDC) for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract has an ultimate completion date of February 14, 2025 and is a firm fixed-price arrangement. The contract does not have a set-aside...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract has a completion date of June 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a ceiling value of $1,690.80 and a performance period through May 15, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OMNIPAQUE 300 MG/ML PLUSPAK 500ML. The contract is a firm-fixed-price contract with a ceiling value of $1,522.16 and a period of performance through June 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a ceiling value of $2,011.96 and a period of performance through April 29, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition....
This federal contract award, valued at $1,171.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 300 MG/ML INFU BTL 100ML, a medical product, with a completion date of February 12, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...